Kadcyla 160 mg Injection
$2.821,14
$2.597,69
Kadcyla 160 mg injection is a targeted therapy designed for individuals diagnosed with specific types of breast cancer, particularly those characterized by high levels of the HER2 protein. This innovative medication combines a monoclonal antibody with a microtubule inhibitor, effectively delivering treatment directly to cancer cells while minimizing damage to healthy tissues. By binding to the HER2 protein on cancer cells, Kadcyla disrupts their growth and proliferation, offering a strategic approach to combatting aggressive breast cancer. Patients should be aware of potential side effects, including fatigue, nausea, and infusion-related reactions, which necessitate close monitoring during treatment. It’s essential to discuss any pre-existing health conditions and medications with your healthcare provider prior to starting Kadcyla to ensure safe administration. With its targeted action, Kadcyla is paving the way for more personalized cancer treatments, giving hope to those affected by HER2-positive breast cancer. Always consult with your oncologist to determine if Kadcyla is the right choice for your specific situation.
數量
Active Pharmaceutical Ingredient
Uses
• Kadcyla 160 mg injection is primarily used in the treatment of early breast cancer (EBC) in patients who have residual invasive disease following surgery and chemotherapy. This medication helps target and destroy cancer cells, minimizing the risk of recurrence. By delivering targeted therapy, Kadcyla 160 mg injection enhances the chances of improved outcomes in this patient population. It is an essential option for patients looking to reduce their risk after initial treatments.
• For those diagnosed with metastatic breast cancer (MBC), Kadcyla 160 mg injection serves as a critical therapeutic option. It is designed for patients who have previously received treatment with trastuzumab and a taxane. The injection works by specifically targeting cancer cells while sparing healthy tissue, which can lead to better management of the disease. This targeted approach is particularly beneficial for individuals facing advanced stages of breast cancer.
• Kadcyla 160 mg injection is also indicated for patients with HER2-positive breast cancer, which is a specific subtype known for its aggressive nature. By utilizing Kadcyla 160 mg injection, healthcare providers can offer a tailored treatment plan that addresses the unique characteristics of HER2-positive tumors. This targeted therapy is instrumental in improving the quality of life for patients battling this form of breast cancer. The use of Kadcyla 160 mg injection highlights the advancement in personalized cancer treatment strategies.
• In clinical practice, Kadcyla 160 mg injection is often utilized as part of a comprehensive treatment regimen for breast cancer patients. It is typically administered after other therapies have been tried, making it a valuable option for those who may have limited choices left. The injection is aimed at controlling the progression of the disease and is a key element in the ongoing management of breast cancer. By incorporating Kadcyla 160 mg injection, healthcare teams can provide more effective and focused care for their patients.
Benefits
Early Breast cancer: Kadcyla 160 mg Injection helps to treat initial stages of breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Kadcyla 160 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Metastatic breast cancer: Kadcyla 160 mg Injection helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. This medicine is used when other medicines have not shown significant improvement and cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Kadcyla 160 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Side Effects
Like all medication, Kadcyla 160 mg Injection may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Decrease platelet count
• Nausea
• Decrease red blood cells
• Decrease white blood cells
• Increased liver enzymes
• Decrease potassium
• Musculoskeletal Pain
• Fatigue
• Headache
• Diarrhea
• Constipation
• Vomiting
• Fever
• Abdominal pain
• Cough
• Peripheral neuropathy
• Weakness
• Mouth sores
• Nose bleeds
• Dry mouth
• Insomnia (Trouble in sleeping)
• Rash
• Dizziness
• Shortness of breath
• Constipation
• Increase bilirubin
Common Side Effects
• Yellowing of the skin or eyes
• Dark Urine or bloody or black, tarry stools
• Body Infections signs: Chills, Fever, ear or sinus pain, very bad sore throat, difficulty urinating, cough without or with spatum, wounds that will not heal.
• Rightside abdominal pain
• Bloody vomiting
• Difficulty in swallowing or breathing
• Nosebleeds
How To Use
Kadcyla 160 mg Injection is in power form to be mixed it with liuid and slowly injected (infused) into a body vein by a health care professional, doctor or nurse in a medical facility or hospital. The dosage schedule depends on your how well your body reacts to the medication and side effect of the medication you experience. Dosage and frequency will be decided by your doctor, If you experience any serious side effect, inform your doctor immediately.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Kadcyla 160 mg Injection. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Kadcyla 160 mg. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: If you suffering from kidney disease, please consult the doctor before taking Kadcyla 160 mg Injection. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
• Breastfeeding: It is not recommended to breastfeed while taking Kadcyla 160 mg. Kadcyla 160 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Kadcyla 160 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: If you suffering from liver disease, please consult the doctor before taking Kadcyla 160 mg Injection. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
• Pregnancy: Use of Kadcyla 160 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Kadcyla 160 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Kadcyla 160 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Kadcyla 160 mg.